首页> 外文期刊>RSC Advances >MiR-19b alleviates MPP+-induced neuronal cytotoxicity via targeting the HAPLN4/MAPK pathway in SH-SY5Y cells
【24h】

MiR-19b alleviates MPP+-induced neuronal cytotoxicity via targeting the HAPLN4/MAPK pathway in SH-SY5Y cells

机译:MiR-19B通过靶向SH-SY5Y细胞中的HAPLN4 / MAPK途径来减轻MPP +-诱导的神经元细胞毒性

获取原文
获取原文并翻译 | 示例
           

摘要

Background: miR-19b has been reported to be involved in nervous system disease including Parkinson's disease (PD). However its molecular basis has not been exhaustively elucidated. Materials and Methods: SH-SY5Y cells were treated with 1-methyl-4-phenylpyridinium (MPP+) to construct PD model in vitro. RT-qPCR was performed to detect the expression of miR-19b and proteoglycan link protein 4 (HAPLN4) mRNA. Western blot analysis was used to measure the level of HAPLN4 and mitogen activated protein kinase (MAPK)-related protein. Cell viability and apoptosis were determined by MTT and flow cytometry. Commercial ELISA kits were applied to quantify caspase-3 activity, lactate dehydrogenase (LDH), reactive oxygen species (ROS), superoxide dismutase (SOD), tumor necrosis factor- (TNF-) and interleukin-1 beta (IL-1). Dual-luciferase reporter assay was applied to assess the relationship between miR-19b and HAPLN4. Results: miR-19b was downregulated in MPP+-induced SH-SY5Y cells. miR-19b overexpression reversed MPP+-induced suppression of cell viability and promotion of cell apoptosis in SH-SY5Y cells. Moreover, miR-19b alleviated MPP+-induced cytotoxicity of SH-SY5Y cells, embodied by the decrease of LDH release, caspase-3 activity, ROS expression, TNF- and IL-1 secretion, as well as the increase of SOD level. HAPLN4 was identified as a direct target of miR-19b and miR-19b repressed HAPLN4 expression in a post-transcriptional manner. In addition, miR-19b-mediated anti-apoptosis effect was abated following HAPLN4 expression restoration in MPP+-induced SH-SY5Y cells. Furthermore, MAPK signaling participated in miR-19b/HAPLN4-mediated regulation in MPP+-treated SH-SY5Y cells. Conclusion: the neuroprotective effect of miR-19b might be mediated by HAPLN4/MAPK pathway in SH-SY5Y cells.
机译:背景:据报道MiR-19B涉及神经系统疾病,包括帕金森病(PD)。然而,它的分子基础并未被详尽阐释。材料和方法:用1-甲基-4-苯基吡啶(MPP +)处理SH-SY5Y细胞以在体外构建PD模型。进行RT-QPCR以检测miR-19b和蛋白多糖链路蛋白4(hapln4)mRNA的表达。用于测量HAPLN4和丝裂原活化蛋白激酶(MAPK)相关蛋白水平的蛋白质印迹分析。通过MTT和流式细胞术测定细胞活力和细胞凋亡。应用商业ELISA试剂盒来量化Caspase-3活性,乳酸脱氢酶(LDH),反应性氧物质(ROS),超氧化物歧化酶(SOD),肿瘤坏死因子(TNF-)和白细胞介素-1β(IL-1)。施用双荧光素酶报告器测定以评估miR-19b和hapln4之间的关系。结果:MIR-19B在MPP +-诱导的SH-SY5Y细胞中下调。 miR-19b过表达逆转MPP +诱导细胞活力和促进SH-SY5Y细胞细胞凋亡的抑制。此外,MIR-19B缓解了MPP +-诱导了SH-SY5Y细胞的细胞毒性,其通过LDH释放,Caspase-3活性,ROS表达,TNF和IL-1分泌的降低而体现,以及SOD水平的增加。 HAPLN4被鉴定为miR-19b和miR-19b的直接靶标以转录后的方式以术后的方式抑制HAPLN4表达。此外,在MPP +-诱导的SH-SY5Y细胞中,在HAPLN4表达恢复之后减少miR-19B介导的抗凋亡效应。此外,MAPK信号传导参与MIR-19B / HAPLN4介导的MPP +-治疗SH-SY5Y细胞调节。结论:MIR-19B的神经保护作用可能是SH-SY5Y细胞中HAPLN4 / MAPK途径介导的。

著录项

  • 来源
    《RSC Advances》 |2018年第19期|共9页
  • 作者

    Liu Wei; Geng Lijiao; Chen Yong;

  • 作者单位

    Henan Univ Dept Neurol Huaihe Hosp Kaifeng 475000 Peoples R China;

    Henan Univ Dept Neurol Huaihe Hosp Kaifeng 475000 Peoples R China;

    Henan Univ Dept Rehabil Med Huaihe Hosp 357 Ximen St Kaifeng 475000 Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 化学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号